US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30 | 138 | 444 | 19 | 81 |
| Receivables | 35 | 34 | 107 | 54 | 22 |
| Inventories | 2 | 5 | 4 | 5 | 5 |
| TOTAL | $81 | $199 | $641 | $88 | $118 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $81 | $199 | $641 | $88 | $118 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,398 | 1,398 | 1,398 | 1,398 | 1,398 |
| Accounts payable and accrued liabilities | 2,214 | 2,185 | 2,084 | 2,143 | 2,029 |
| Accrued Expenses | 1,825 | 1,689 | 1,546 | 1,511 | 1,380 |
| Other current liabilities | 465 | 465 | 465 | 465 | 465 |
| TOTAL | $11,634 | $11,286 | $10,960 | $10,848 | $10,468 |
| Non-Current Liabilities | |||||
| Long Term Debt | 732 | 741 | 749 | 760 | 770 |
| Deferred Revenues | 3 | 3 | 2 | 3 | 23 |
| TOTAL | $789 | $799 | $808 | $820 | $830 |
| Total Liabilities | $12,423 | $12,085 | $11,768 | $11,667 | $11,298 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 480,957 | 456,218 | 452,413 | 452,413 | 452,413 |
| Common Shares | 461 | 452 | 450 | 436 | 430 |
| Retained earnings | -139,161 | -138,489 | -137,494 | -136,515 | -135,925 |
| TOTAL | $-12,342 | $-11,886 | $-11,127 | $-11,579 | $-11,180 |
| Total Liabilities And Equity | $81 | $199 | $641 | $88 | $118 |